When we investigated specific items of the MOCA and SCOPA-AUT scales within the subgroups of GBA1 variant carriers, we identified that visuospatial abilities and pupillomotor function were mainly affected in severe GBA1-PD compared with iPD and risk GBA1-PD (Supplementary Tables 2 and 4). This evidence concerns the gene GBA1 and Parkinson disease.